US PAYER VIEWPOINTS ON, AND USE OF, REAL WORLD EVIDENCE (RWE)

被引：0
|
作者：
Kelly, K. [1 ]
Martin, M. [2 ]
Roberts, T. [3 ]
机构：
[1] InVentiv Hlth Consulting, New York, NY USA
[2] inVentiv Hlth, London, England
[3] inVentiv Hlth Consulting, Morristown, NJ USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP169
引用
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [31] Real World Evidence (RWE) in der PhytotherapiePerspektiven für den Aufbau eines Registers zur Nutzung von PhytopharmakaReal world evidence (RWE) in phytotherapyPerspectives for the development of a registry for phytopharmaceuticals
    Michael Habs
    Theodor Dingermann
    Beatrice E. Bachmeier
    Björn Eskofier
    Benjamin Friedrich
    Lukas Prantl
    Jens Emmer
    Jost Langhorst
    Tobias Dreischulte
    Michael Koller
    [J]. Zeitschrift für Allgemeinmedizin, 2023, 99 (4): : 182 - 189
  • [32] Real-world (RW) use of venetoclax (VEN) in patients (pts) with acute myeloid leukemia (AML) in a US RWE database (COTA)
    Zeidan, Amer Methqal
    Donoso, Leyla Hernandez
    Hodzic, Sejla
    Owusu, Henry F.
    Pathak, Dhrubajyoti
    Zhou, Summera Qiheng
    Stein, Eytan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Using real-world evidence (RWE) in regulatory decision making: A study of 6 oncology approvals with RWE included in the product label
    Zong, Jihong
    Jiao, Xiaolong
    Pan, Lucy
    Castelo, Sarah
    Campbell, Chelsey
    Lennert, Barb
    Bruno, Amanda
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design
    Andrew D. Xia
    Caroline P. Schaefer
    Agota Szende
    Elke Jahn
    Matthew J. Hirst
    [J]. Drugs - Real World Outcomes, 2019, 6 : 193 - 203
  • [35] Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
    Maison, Patrick
    Zureik, Mahmoud
    Hivert, Virginie
    Kjaer, Jesper
    Khonsari, Roman Hossein
    Trifiro, Gianluca
    Ratignier-Carbonneil, Christelle
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] PREVALENCE AND INCIDENCE ESTIMATIONS IN GERMAN AMNOG APPLICATIONS - THE ROLE OF REAL-WORLD EVIDENCE (RWE)
    Altevers, J.
    Borchert, K.
    Mittendorf, T.
    Braun, S.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A558 - A558
  • [37] Real-world evidence (RWE) study to access motor vehicle accidents data: Real-world data landscaping and feasibility
    Li, Hu
    Phinney, Michael
    Khanna, Rashna
    Bragg, Sonja M.
    Clemmer, Tammy
    Oakkar, Eva
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 611 - 611
  • [38] USING REAL WORLD EVIDENCE (RWE) TO ASSESS DRUG-DRUG INTERACTION (DDI) BETWEEN PAXLOVID AND THE TOP 100 PRESCRIBED DRUGS IN THE US
    Gerhart, J.
    Draica, F.
    Benigno, M.
    Sidhu, G.
    Atkinson, J.
    Reimbaeva, M.
    Francis, D.
    Baillon-Plot, N.
    Damle, B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S17 - S17
  • [39] USING REAL WORLD EVIDENCE (RWE) TO ASSESS DRUG-DRUG INTERACTION (DDI) BETWEEN PAXLOVID AND THE TOP 100 PRESCRIBED DRUGS IN THE US
    Gerhart, J.
    Draica, F.
    Benigno, M.
    Sidhu, G.
    Atkinson, J.
    Reimbaeva, M.
    Francis, D.
    Baillon-Plot, N.
    Damle, B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S5 - S5
  • [40] IS THERE A NEED FOR REAL WORLD EVIDENCE (RWE) IN HEALTH TECHNOLOGY ASSESSMENTS OF RARE DISEASES AND ONCOLOGY TREATMENTS?
    Forsythe, A.
    Tomaras, D.
    Badia, F. J.
    Pirk, O.
    Rowe, P.
    Bergman, J. F.
    Walker, A.
    Fricke, F. U.
    Tremblay, G.
    [J]. VALUE IN HEALTH, 2019, 22 : S811 - S811
12345